These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 526339)
21. Inhibition of mitogen mediated lymphocyte blastogenesis by adenosine. Fox IH; Keystone EC; Gladman DD; Moore M; Cane D Immunol Commun; 1975; 4(5):419-27. PubMed ID: 1205504 [TBL] [Abstract][Full Text] [Related]
22. Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance. Dhasmana JP; Digerness SB; Geckle JM; Ng TC; Glickson JD; Blackstone EH J Cardiovasc Pharmacol; 1983; 5(6):1040-7. PubMed ID: 6196552 [TBL] [Abstract][Full Text] [Related]
23. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863 [TBL] [Abstract][Full Text] [Related]
24. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine. Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608 [TBL] [Abstract][Full Text] [Related]
25. Purine excretion by mouse peritoneal macrophages lacking adenosine deaminase activity. Chan TS Proc Natl Acad Sci U S A; 1979 Feb; 76(2):925-9. PubMed ID: 311477 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA. Lupidi G; Cristalli G; Marmocchi F; Riva F; Grifantini M J Enzyme Inhib; 1985; 1(1):67-75. PubMed ID: 3916912 [TBL] [Abstract][Full Text] [Related]
27. Identification of the bioactive enantiomer of erythro-3-(adenin-9-yl)-2-nonanol (EHNA), a semi-tight binding inhibitor of adenosine deaminase. Baker DC; Hanvey JC; Hawkins LD; Murphy J Biochem Pharmacol; 1981 May; 30(10):1159-61. PubMed ID: 7259798 [No Abstract] [Full Text] [Related]
28. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism. Simmonds HA; Panayi GS; Corrigall V Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565 [TBL] [Abstract][Full Text] [Related]
29. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues. North TW; Cohen SS Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993 [TBL] [Abstract][Full Text] [Related]
30. Elucidation of aberrant purine metabolism: application to hypoxanthine-guanine phosphoribosylstransferase- and adenosine kinase-deficient mutants, and IMP dehydrogenase- and adenosine deaminase-inhibited human lymphoblasts. Snyder FF; Trafzer RJ; Hershfield MS; Seegmiller JE Biochim Biophys Acta; 1980 Oct; 609(3):492-501. PubMed ID: 6108130 [TBL] [Abstract][Full Text] [Related]
32. Catabolism of adenine nucleotides in adenosine deaminase deficient erythrocytes. Mills GC; Goldblum RM; Schmalstieg FC Life Sci; 1981 Oct; 29(17):1811-20. PubMed ID: 7300574 [No Abstract] [Full Text] [Related]
33. Transendothelial transport and metabolism of adenosine and inosine in the intact rat aorta. Kroll K; Kelm MK; Bürrig KF; Schrader J Circ Res; 1989 Jun; 64(6):1147-57. PubMed ID: 2720915 [TBL] [Abstract][Full Text] [Related]
34. Effects of 6,9-disubstituted 8-azapurines on adenosine deaminase, guanine deaminase and xanthine oxidase. Lucacchini A; Bazzichi L; Biagi G; Livi O; Segnini D Ital J Biochem; 1982; 31(3):153-62. PubMed ID: 6897062 [No Abstract] [Full Text] [Related]
35. The protonated form of 1-N6-etheno-[erythro-9-(2-hydroxy-3-nonyl)] adenine is identified at the active site of adenosine deaminase. Caiolfa VR; Gill D; Parola AH FEBS Lett; 1990 Jan; 260(1):19-22. PubMed ID: 2153576 [TBL] [Abstract][Full Text] [Related]
36. Adenosine deaminase inhibition and myocardial adenosine metabolism during ischemia. Achterberg PW; de Jong JW Adv Myocardiol; 1985; 6():465-72. PubMed ID: 3992044 [TBL] [Abstract][Full Text] [Related]
37. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. Snyder FF; Mendelsohn J; Seegmiller JE J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393 [TBL] [Abstract][Full Text] [Related]
38. Adenosine deaminase inhibitors: differential effects on multiple forms of adenosine deaminase. Constine J; Glazer RI; Johns DG Biochem Biophys Res Commun; 1978 Nov; 85(1):198-202. PubMed ID: 570397 [No Abstract] [Full Text] [Related]
39. The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation. Kayhan N; Funke B; Conzelmann LO; Winkler H; Hofer S; Steppan J; Schmidt H; Bardenheuer H; Vahl CF; Weigand MA Crit Care; 2008; 12(5):R125. PubMed ID: 18847498 [TBL] [Abstract][Full Text] [Related]
40. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine. Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]